home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...

AAH Pharmaceuticals

The UK's leading wholesaler and distributor of pharmaceutical and healthcare products and services to pharmacy, hospitals and doctors. Supplying a full range of healthcare products including ethicals, generics, PIs and OTCs.

RELATED NEWS


Boehringer Ingelheim was the last man standing among challengers to AbbVie’s patents on immunology blockbuster Humira but has joined the pack and settled its litigation. The German company has agreed to delay the introduction of its Humira (adalimumab) biosimilar Cyltezo until 2023, following the example of Amgen, Merck & Co/Samsung Bioepis, Mylan/Fujifilm and Novartis’ Sandoz unit. AbbVie now has breathing space in the US to try to reduce its over-reliance on Humira, which broug...

READ MORE

A small population of brain cells deep in a memory-making region of the brain controls the production of new neurons and may have a role in common brain disorders, according to a study from scientists at the University of North Carolina School of Medicine. The scientists, who published their work in Neuron, showed that "mossy cells" in the hippocampus regulate local stem cells to control their production of new neurons, which is important for normal learning and memory, stress response...
UNIVERSITY OF NORTH CAROLINA HEALTH CARE
READ MORE

Deutsche Bank is hopeful of better health of pharma stocks going forward due to easing regulatory concerns as well as actions by the US Food and Drug Administration (FDA). The brokerage remains constructive on stocks with superior earnings growth trajectory and strong execution track record. “We forecast the sector to post an 18% CAGR in FY16- 18 (20% CAGR over FY13-16), led by Sun Pharmaceuticals (32%), Aurobindo Pharma (21%) and Glenmark (45%),” the report said. Its top bets are Aurobindo ...

READ MORE

Chasing biosim partners Mylan and Biocon for one of the top sales targets in the pharma industry, Celltrion reported Sunday that its version of Roche’s breast cancer med Herceptin stacked up to the reference blockbuster in a late-stage trial....

READ MORE

The Pharmaceutical Services Negotiating Committee PSNC, Department of Health and Social Care DHSC and NHS England have announced a five-year funding framework for community pharmacy. The framework agreement for community pharmacies announced funding of almost 13 billion pounds over the five years to 2023-24, with 2.592 billion pounds per year, for pharmacies. The announcement also states that a new NHS Community Pharmacist Consultation Service CPCS will be introduced nationally as an advanced se...

READ MORE

Lawmakers in the nation's capital have yet to grapple with rising drug costs, but Ohio voters are being asked in a single ballot-box question next week to figure out how best to lower the tab the state pays for prescriptions....

READ MORE

EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

eyeforpharma Awards 2019
EYEFORPHARMA AWARDS 2019
December 11-11, 2019
You’ll already know if you’re a winner: your patients are telling you. But now it’s time to be recognised by your peers and the wider healthcare community. The eyeforpharma awards are unique. They’re the only awards that focus exclusively on what matters - value for patients ...